Nutrition Biofiles7

Total Page:16

File Type:pdf, Size:1020Kb

Nutrition Biofiles7 2007 Volume 2 Number 2 FOR LIFE SCIENCE RESEARCH DIETARY ANTIOXIDANTS OMEGA-3 FATTY ACIDS AND HEART DISEASE THE BIOACTIVE NUTRIENT EXPLORER METABOLITE LIBRARIES Examples of fruits and vegetables that contain antioxidants such as kaempferol, lycopene, and resveratrol. Nutrition Research sigma-aldrich.com Life Science Pathways Animated ATP Synthase & Glycolysis! The evolutionary pathway of life science research has brought today’s researchers full circle to a destination we now call metabolomics. n 1947, Sigma produced the first commercially The Enzyme Explorer’s Metabolic Pathways The Enzyme Explorer I available ATP. Since then, Sigma-Aldrich has Resource Center provides the online tools you need Assay Library consistently expanded its product portfolio to to explore the metabolome today. The largest collection of enzymatic maintain the most comprehensive line of organic • Metabolic Pathway Chart with 500 Hyperlinks assay procedures available online. More than 600 step-by-step metabolites, enzymes, and bio-analytical tools in to Product Listings, and Technical Data procedures for: the world. • Direct Access to 35 Nicholson Metabolic Mini-maps To strengthen our commitment to metabolic METABOLIC ENZYMES • Animated ATP Synthase Mechanism METABOLITE QUANTITATION education and research, Sigma-Aldrich is proud DIAGNOSTIC ENZYMES to announce the formation of a collaboration • Animated Glycolysis Pathway ANALYTICAL ENZYMES with the IUBMB to produce, animate, and • Isotopically Labeled Metabolites PROTEASES PROTEASE INHIBITORS publish the Nicholson Metabolic Pathway Charts. • Metabolite Libraries CELL SIGNALING ENZYMES PROTEIN QUANTITATION Visit the Assay Library at: sigma-aldrich.com/enzymeexplorer Visit us online today at: sigma-aldrich.com/metpath LEADERSHIP IN LIFE SCIENCE, HIGH TECHNOLOGY AND SERVICE sigma-aldrich.com SIGMA-ALDRICH CORPORATION • BOX 14508 • ST. LOUIS • MISSOURI 63178 • USA 1 Introduction For most of the world’s population, foods and other plant and animal materials are consumed not only for their nutritional value, but also because they contain bioactive FOR LIFE SCIENCE RESEARCH compounds that can prevent or treat diseases. Even in developed or rapidly developing 2007 economies, such as Japan, South Korea, China, and India, traditional medicines primarily derived from plant sources continue to be used along side, and often in preference to, Volume 2 modern pharmaceuticals. Throughout history, human populations have learned either by Number 2 serendipity or by observation the properties of materials present in their environment. Even the most primitive societies, by modern standards, often had fairly sophisticated knowledge of the medicinal properties of local plants. This knowledge may have been Table of Contents passed down orally for centuries as the exclusive province of medicine men or shamans. Over time, this knowledge often became documented and codified, as in the Greco- Nutrition Research Roman, Unani, Ayurvedic, or traditional Chinese pharmacopoeias and medical practices. More recently, research interest in complementary and alternative medicine has surged as Western societies have embraced traditional herbal preparations and functional foods Dietary Antioxidants ........................................2 for their purported disease prevention and therapeutic properties. The global market Amino Acids and Peptides .....................................3 for dietary supplements and functional foods was approximately $145 billion in 2005, Flavonoids ............................................................5 of which $48 billion was within the U.S. Consumers perceive herbal source materials as Coumarins, Lignins and Stibenes .........................10 safer than pharmaceuticals; in some cases there is research to support this view. Foods Isoprenoids and Carotenoids ...............................10 and herbs often contain several compounds with the same primary physiological effect Minerals .............................................................12 but differing secondary actions. Thus, the beneficial effect is due to the combined action Additional Antioxidants .......................................12 of several chemical entities, most of which are in low enough concentration to minimize secondary negative side effects. Omega-3 Fatty Acids and Heart Disease .....14 From micronutrients to drugs of abuse, nutritionists, pharmacologists, and medical Omega-3 Polyunsaturated researchers are studying the physiological, therapeutic, and chemopreventive properties Fatty Acids and Precursor ................................16 of foods and herbs and their constituents. This issue of BioFiles highlights some of the Omega-6 Polyunsaturated Fatty Acids .................17 product groups available from Sigma-Aldrich to further this research, with special focus Lipid Metabolism Related Products .....................17 on omega-3 (w-3) fatty acids and antioxidant compounds such as carotenoids and Lipid Mediator Related Products .........................17 polyphenols. We also introduce the Bioactive Nutrient Explorer, an interactive database on the Sigma-Aldrich web site that allows researchers to find plants of interest based on The Bioactive Nutrient Explorer ...................18 their physiological actions, plant constituents based on their chemical structure, and the chemical constituents of specific herbs and food plants. Metabolite Libraries .......................................20 Amino Acid Metabolite Library ............................20 Carbohydrate Metabolite Library .........................21 Lipid Metabolite Library ......................................22 LabwareNotes .................................................23 Stay One Step Ahead... Subscribe Now To BioFiles Discover the Features and Benefits of FTA® Technology in LabwareNotes (pages 23-24) Each issue highlights products and services specifi c to the Life Sciences. Register to Receive Your BioFiles. To register visit us online at sigma-aldrich.com/biofi les2 For Hazard Information and other information please refer to the Sigma Biochemicals, Reagents and Kits for Life Science Research Catalog or sigma-aldrich.com 2 Dietary Antioxidants Dietary Antioxidants OH Antioxidants protect biological systems from oxidative damage O produced by oxygen-containing free radicals and from redox- O active transition metal ions such as iron, copper, and cadmium.1 HO During the oxidative metabolism of glucose in the mitochondria, – superoxide anions (O2 ) are produced as a by-product of the Figure 2. Structure of astaxanthin reduction of coenzyme Q complex III. The enzyme superoxide dismutase converts superoxide anions to hydrogen peroxide Some antioxidants trap or scavenge the free radicals, and in (H2O2) that in turn can be converted to peroxyl radicals (RO2•), the process become radicals themselves. When the carotenoids – – hydroxyl radicals (OH •), or hypochlorite (ClO ) ions. Superoxide astaxanthin (see Figure 2), lutein, and zeaxanthin scavenge anions can also react with nitric oxide (NO) to form the highly oxygen free radicals, the charge of the unpaired electron becomes – 2 reactive peroxynitrite (ONOO •). Under normal conditions these delocalized over the entire polyene chain of the molecule.9 The cellular oxidants are reduced or scavenged by the intracellular flavonol quercetin is oxidized to a quinone that can react with antioxidants and antioxidant enzymes, the most important thiols.10 Flavonoids are also excellent metal ion chelators and can of which are glutathione, thioredoxin, superoxide dismutase, prevent copper-catalyzed peroxidation of LDL.1,4,11 The stilbene catalase, and peroxidase. Dietary antioxidants, such as ascorbic phytoalexin resveratrol is more potent than the flavonoids in acid (vitamin C), vitamin E, β-carotene and other carotenoids, and chelating copper and preventing peroxidation of LDL.12 This likely selenium have been recognized as important contributors to the contributes to the antiatherosclerotic actions of resveratrol and the total antioxidant capacity of cells and plasma. The carotenoids flavonoids. lutein and zeaxanthin are important antioxidants in the eye and Flavonoids and carotenoids, the major dietary antioxidants, are retina.3 Vitamin E, a mixture of tocopherols and tocotrienols, of ubiquitous in fruits and vegetables. Epidemiological studies which α-tocopherol is the major antioxidant,4 is the major lipid indicate that populations with diets high in these phytochemicals soluble antioxidant in cells and plays a major role in protecting 2 also have lower incidence rates of chronic diseases associated Dietary Antioxidants membrane lipids from peroxidation. Low density lipoproteins with oxidative stress, such as atherosclerosis, diabetes, (LDL) carry vitamin E into cells, which subsequently prevents neurodegenerative diseases, and cancer.8 However, there is much the peroxidation of LDL by donating hydrogen to fatty peroxyl disagreement concerning the mechanism of action of polyphenols radicals.5 Polyphenolic compounds, especially the flavonoids, have in vivo. Polyphenols are treated as xenobiotics by the body and recently been shown to be potent antioxidants in cultured cells. are rapidly metabolized and conjugated in the intestinal lining Human studies of flavonoids have also demonstrated effects that and liver. With the exception of the gallic acid conjugates of the can in part be attributed to their antioxidant action.6 catechins, such as epigallocatechin gallate,13 most flavonoids in Antioxidants can act
Recommended publications
  • Herbal Insomnia Medications That Target Gabaergic Systems: a Review of the Psychopharmacological Evidence
    Send Orders for Reprints to [email protected] Current Neuropharmacology, 2014, 12, 000-000 1 Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence Yuan Shia, Jing-Wen Donga, Jiang-He Zhaob, Li-Na Tanga and Jian-Jun Zhanga,* aState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China; bDepartment of Pharmacology, School of Marine, Shandong University, Weihai, P.R. China Abstract: Insomnia is a common sleep disorder which is prevalent in women and the elderly. Current insomnia drugs mainly target the -aminobutyric acid (GABA) receptor, melatonin receptor, histamine receptor, orexin, and serotonin receptor. GABAA receptor modulators are ordinarily used to manage insomnia, but they are known to affect sleep maintenance, including residual effects, tolerance, and dependence. In an effort to discover new drugs that relieve insomnia symptoms while avoiding side effects, numerous studies focusing on the neurotransmitter GABA and herbal medicines have been conducted. Traditional herbal medicines, such as Piper methysticum and the seed of Zizyphus jujuba Mill var. spinosa, have been widely reported to improve sleep and other mental disorders. These herbal medicines have been applied for many years in folk medicine, and extracts of these medicines have been used to study their pharmacological actions and mechanisms. Although effective and relatively safe, natural plant products have some side effects, such as hepatotoxicity and skin reactions effects of Piper methysticum. In addition, there are insufficient evidences to certify the safety of most traditional herbal medicine. In this review, we provide an overview of the current state of knowledge regarding a variety of natural plant products that are commonly used to treat insomnia to facilitate future studies.
    [Show full text]
  • Review Article Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 238482, 26 pages http://dx.doi.org/10.1155/2015/238482 Review Article Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development Charu Sharma,1 Bassem Sadek,2 Sameer N. Goyal,3 Satyesh Sinha,4 Mohammad Amjad Kamal,5,6 and Shreesh Ojha2 1 Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, UAE 2Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, UAE 3DepartmentofPharmacology,R.C.PatelInstituteofPharmaceuticalEducation&Research,Shirpur,Mahrastra425405,India 4Department of Internal Medicine, College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA 5King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia 6Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770, Australia Correspondence should be addressed to Shreesh Ojha; [email protected] Received 24 April 2015; Accepted 24 August 2015 Academic Editor: Ki-Wan Oh Copyright © 2015 Charu Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The cannabinoid molecules are derived from Cannabis sativa plant which acts on the cannabinoid receptors types 1 and 2 (CB1 and CB2) which have been explored as potential therapeutic targets for drug discovery and development. Currently, there are 9 numerous cannabinoid based synthetic drugs used in clinical practice like the popular ones such as nabilone, dronabinol, and Δ - tetrahydrocannabinol mediates its action through CB1/CB2 receptors.
    [Show full text]
  • NRDC: Generally Recognized As Secret
    NRDC Report April 2014 Generally Recognized as Secret: Chemicals Added to Food in the United States Tom Neltner, J.D., Maricel Maffini, Ph.D. Natural Resources Defense Council In April 2014, the Natural Resources Defense Council (NRDC) released a report raising concerns about a loophole in the Food Additives Amendment of 1958 for substances designated by food manufacturers as “generally recognized as safe” (GRAS). The report identified 56 companies that appeared to market 275 chemicals for use in food based on undisclosed GRAS safety determinations. For each chemical we identified in this study, we did not find evidence that FDA had cleared them for use in food. The 1958 law exempted from the formal, extended FDA approval process common food ingredients like vinegar and vegetable oil whose use qualifies as GRAS. It may have appeared reasonable at the time, but that exemption has been stretched into a loophole that has swallowed the law. The exemption allows manufacturers to make safety determinations that the uses of their newest chemicals in food are safe without notifying the FDA. The agency’s attempts to limit these undisclosed GRAS determinations by asking industry to voluntarily inform the FDA about their chemicals are insufficient to ensure the safety of our food in today’s global marketplace with a complex food supply. Furthermore, no other developed country in the world has a system like GRAS to provide oversight of food ingredients. In Table 1 and 2 of the report, NRDC identified the 56 companies and the number of chemicals that each company appeared to market as GRAS without FDA clearance.
    [Show full text]
  • Herbal Remedies and Their Possible Effect on the Gabaergic System and Sleep
    nutrients Review Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep Oliviero Bruni 1,* , Luigi Ferini-Strambi 2,3, Elena Giacomoni 4 and Paolo Pellegrino 4 1 Department of Developmental and Social Psychology, Sapienza University, 00185 Rome, Italy 2 Department of Neurology, Ospedale San Raffaele Turro, 20127 Milan, Italy; [email protected] 3 Sleep Disorders Center, Vita-Salute San Raffaele University, 20132 Milan, Italy 4 Department of Medical Affairs, Sanofi Consumer HealthCare, 20158 Milan, Italy; Elena.Giacomoni@sanofi.com (E.G.); Paolo.Pellegrino@sanofi.com (P.P.) * Correspondence: [email protected]; Tel.: +39-33-5607-8964; Fax: +39-06-3377-5941 Abstract: Sleep is an essential component of physical and emotional well-being, and lack, or dis- ruption, of sleep due to insomnia is a highly prevalent problem. The interest in complementary and alternative medicines for treating or preventing insomnia has increased recently. Centuries-old herbal treatments, popular for their safety and effectiveness, include valerian, passionflower, lemon balm, lavender, and Californian poppy. These herbal medicines have been shown to reduce sleep latency and increase subjective and objective measures of sleep quality. Research into their molecular components revealed that their sedative and sleep-promoting properties rely on interactions with various neurotransmitter systems in the brain. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that plays a major role in controlling different vigilance states. GABA receptors are the targets of many pharmacological treatments for insomnia, such as benzodiazepines. Here, we perform a systematic analysis of studies assessing the mechanisms of action of various herbal medicines on different subtypes of GABA receptors in the context of sleep control.
    [Show full text]
  • Therapeutic Applications of Compounds in the Magnolia Family
    Pharmacology & Therapeutics 130 (2011) 157–176 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Associate Editor: I. Kimura Therapeutic applications of compounds in the Magnolia family Young-Jung Lee a, Yoot Mo Lee a,b, Chong-Kil Lee a, Jae Kyung Jung a, Sang Bae Han a, Jin Tae Hong a,⁎ a College of Pharmacy and Medical Research Center, Chungbuk National University, 12 Gaesin-dong, Heungduk-gu, Cheongju, Chungbuk 361-763, Republic of Korea b Reviewer & Scientificofficer, Bioequivalence Evaluation Division, Drug Evaluation Department Pharmaceutical Safety Breau, Korea Food & Drug Administration, Republic of Korea article info abstract Keywords: The bark and/or seed cones of the Magnolia tree have been used in traditional herbal medicines in Korea, Magnolia China and Japan. Bioactive ingredients such as magnolol, honokiol, 4-O-methylhonokiol and obovatol have Magnolol received great attention, judging by the large number of investigators who have studied their Obovatol pharmacological effects for the treatment of various diseases. Recently, many investigators reported the Honokiol anti-cancer, anti-stress, anti-anxiety, anti-depressant, anti-oxidant, anti-inflammatory and hepatoprotective 4-O-methylhonokiol effects as well as toxicities and pharmacokinetics data, however, the mechanisms underlying these Cancer Nerve pharmacological activities are not clear. The aim of this study was to review a variety of experimental and Alzheimer disease clinical reports and, describe the effectiveness, toxicities and pharmacokinetics, and possible mechanisms of Cardiovascular disease Magnolia and/or its constituents. Inflammatory disease © 2011 Elsevier Inc. All rights reserved. Contents 1. Introduction .............................................. 157 2. Components of Magnolia ........................................ 159 3. Therapeutic applications in cancer ...................................
    [Show full text]
  • Synthesis of Magnolol and Its Analogue Compounds Synthese Von Magnolol Und Analog-Verbindungen Synthèse De Magnolol Et Ses Composés Analogues
    (19) TZZ ¥¥_Z_T (11) EP 2 539 310 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07C 37/055 (2006.01) C07C 37/62 (2006.01) 16.07.2014 Bulletin 2014/29 C07C 39/21 (2006.01) C07C 41/48 (2006.01) C07C 41/52 (2006.01) C07C 43/313 (2006.01) (2006.01) (2006.01) (21) Application number: 10705965.1 C07C 43/30 A61K 31/05 A61P 31/04 (2006.01) (22) Date of filing: 25.02.2010 (86) International application number: PCT/US2010/025378 (87) International publication number: WO 2011/106003 (01.09.2011 Gazette 2011/35) (54) SYNTHESIS OF MAGNOLOL AND ITS ANALOGUE COMPOUNDS SYNTHESE VON MAGNOLOL UND ANALOG-VERBINDUNGEN SYNTHÈSE DE MAGNOLOL ET SES COMPOSÉS ANALOGUES (84) Designated Contracting States: • SUBRAMANYAM, Ravi AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Belle Mead HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL NJ 08502 (US) PT RO SE SI SK SM TR (74) Representative: Jenkins, Peter David (43) Date of publication of application: Page White & Farrer 02.01.2013 Bulletin 2013/01 Bedford House John Street (73) Proprietors: London WC1N 2BF (GB) •Colgate-Palmolive Company New York, NY 10022 (US) (56) References cited: • Indian Institute Of Chemical Technology US-A1- 2006 140 885 Andhra Pradesh (IN) • J. RUNEBERG: "Phenol Dehydrogenations" (72) Inventors: ACTA CHEMICA SCANDINAVICA, vol. 12, 1958, • REDDY, Basi, V., Subba pages 188-192, XP002575197 cited in the Nacharam (IN) application • YADAV, Jhillu, S.
    [Show full text]
  • Honokiol and Magnolol As Renewable Resources for the Synthesis of Polymers Towards Biomedical and Engineering Applications
    HONOKIOL AND MAGNOLOL AS RENEWABLE RESOURCES FOR THE SYNTHESIS OF POLYMERS TOWARDS BIOMEDICAL AND ENGINEERING APPLICATIONS A Dissertation by KEVIN T. WACKER Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Chair of Committee, Karen L. Wooley Committee Members, Lei Fang Jaime C. Grunlan David C. Powers Head of Department, Simon W. North May 2018 Major Subject: Chemistry Copyright 2018 Kevin T. Wacker ABSTRACT This dissertation has focused on the design, synthesis, and characterization of novel polymers derived from the renewable resources honokiol and magnolol. These natural products – isolated from magnolia officinalis – are highly functional and, thus, amenable to a broad range of synthetic organic transformations. The transformations explored in this work have yielded diverse monomers and, subsequently, polymer types which have included polycarbonates, thermosets, and olefin-based polymers that were studied for potential engineering or biomedical materials. A guiding theme in the development of polymers from honokiol and magnolol has been to control and vary the final polymer properties through the monomer design and polymerization chemistry. This work has used scalable syntheses, well-known chemistries, and, as the first examples of polymers synthesized from these natural products, it has laid the foundation to further explore material applications and new polymers based on honokiol and magnolol. Poly(honokiol carbonate) (PHC) was synthesized in one step from honokiol using step-growth polycondensation techniques. Synthetic conditions were screened to yield polymers of varying molecular weight and the resulting polymers were studied in their thermomechanical and biological properties.
    [Show full text]
  • Honokiol and Magnolol As Multifunctional Antioxidative Molecules for Dermatologic Disorders
    Molecules 2010, 15, 6452-6465; doi:10.3390/molecules15096452 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Honokiol and Magnolol as Multifunctional Antioxidative Molecules for Dermatologic Disorders Jui-Lung Shen 1,2,3,#, Kee-Ming Man 2,4,5,#, Po-Hsun Huang 6, Wen-Chi Chen 4, Der-Cherng Chen 4, Ya-Wen Cheng 1, Po-Len Liu 7,*, Ming-Chih Chou 1,*, and Yung-Hsiang Chen 4,* 1 Institute of Medicine, Chung Shan Medical University, Taichung; Taiwan; E-Mails: [email protected] (J.L.S.); [email protected] (Y.W.C.) 2 Department of Anesthesiology, Tungs’ Taichung MetroHarbor Hospital, Taichung; Taiwan; E-Mail: [email protected] (K.M.M.) 3 Department of Dermatology, Taichung Veterans General Hospital, Taichung; Taiwan 4 Graduate Institute of Integrated Medicine, College of Chinese Medicine, Graduate Institute of Clinical Medical Science, Department of Urology, Department of Neurosurgery, China Medical University and Hospital, Taichung; Taiwan; E-Mails: [email protected] (W.C.C.); [email protected] (D.C.C.); [email protected] (Y.H.C.) 5 Graduate Institute of Geriatric Medicine, Anhui Medical University, Hefei; China 6 Division of Cardiology, Taipei Veterans General Hospital, Institute of Clinical Medicine, Cardiovascular Research Center, National Yang-Ming University, Taipei; Taiwan; E-Mail: [email protected] 7 Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung; Taiwan; E-Mail: [email protected] # Jui-Lung Shen and Kee-Ming Man contributed equally to this study. * Author to whom correspondence should be addressed; E-mail: [email protected] (P.L.); [email protected] (M.C.); [email protected] (Y.C.); Tel.: +886-4-22053366-3512; Fax: +886-4-2203-7690.
    [Show full text]
  • Phytochemicals Having Neuroprotective Properties from Dietary Sources and Medicinal Herbs
    PHCOG J REVIEW ARTICLE Phytochemicals Having Neuroprotective Properties from Dietary Sources and Medicinal Herbs G. Phani Kumar*, K.R. Anilakumar and S. Naveen Applied Nutrition Division, Defence Food Research Laboratory (DRDO), Ministry of Defence, India ABSTRACT Many neuropsychiatric and neurodegenerative disorders, such as Alzheimer's disease, anxiety, cerebrovascular impairment, depression, seizures, Parkinson's disease, etc. are predominantly appearing in the current era due to the stress full lifestyle. Treatment of these disorders with prolonged administration of synthetic drugs will lead to severe side effects. In the recent years, scientists have focused the attention of research towards phytochemicals to cure neurological disorders. Nootropic herb refers to the medicinal role of various plants/parts for their neuroprotective properties by the active phytochemicals including alkaloids, steroids, terpenoids, saponins, phenolics, flavonoids, etc. Phytocompounds from medicinal plants play a major part in maintaining the brain's chemical balance by acting upon the function of receptors for the major inhibitory neurotransmitters. Medicinal plants viz. Valeriana officinalis, Nardostachys jatamansi, Withania somnifera, Bacopa monniera, Ginkgo biloba and Panax ginseng have been used widely in a variety of traditional systems of therapy because of their adaptogenic, psychotropic and neuroprotective properties. This review highlights the importance of phytochemicals on neuroprotective function and other related disorders, in particular
    [Show full text]
  • Expression of Cyclooxygenase-2, Nitric Oxide Synthase 2
    in vivo 31 : 819-831 (2017) doi:10.21873/invivo.11135 Expression of Cyclooxygenase-2, Nitric Oxide Synthase 2 and Heme Oxygenase-1 mRNA Induced by Bis- Eugenol in RAW264.7 Cells and their Antioxidant Activity Determined Using the Induction Period Method YUKIO MURAKAMI, AKIFUMI KAWATA and SEIICHIRO FUJISAWA Division of Oral Diagnosis and General Dentistry, Department of Diagnostic and Therapeutic Sciences, Meikai University School of Dentistry, Sakado, Japan Abstract. Background/Aim: To clarify the mechanisms induced the expression of HO-1 mRNA, and when combined responsible for the anti-inflammatory/proinflammatory with MMI it showed a potent antagonistic effect on BPO- activities of eugenol-related compounds, we investigated the induced antioxidant activity. The ability of methoxyphenols cytotoxicity and up-regulatory/down-refgulatory effects of the to inhibit LPS-stimulated Cox-2 gene expression declined in biphenols curcumin, bis-eugenol, magnolol and honokiol, the order curcumin >> isoeugenol > bis-eugenol >> and the monophenols eugenol and isoeugenol, on major eugenol, and the rank of ability was related to their ω value. regulators of cyclooxygenase-2 (Cox-2), nitric oxide synthase Conclusion: Most eugenol-related compounds had 2 (Nos2) and heme oxygenase-1 (HO-1) mRNA in RAW264.7 proinflammatory activity at high concentrations. However, cells. Materials and Methods: mRNA expression was they had also anti-inflammatory activity at lower investigated using real-time reverse transcriptase- concentrations. Eugenol-related compounds may exert polymerase chain reaction (RT-PCR), and the theoretical antioxidant and anti-inflammatory activity in LPS-stimulated parameters were calculated using the DFT/B3LYP/6-31* RAW264.7 cells possibly by inhibiting the activation of method.
    [Show full text]
  • 1H-Indole-3-Carboxylic Acid Is a Highly Selective Substrate for Glucuronidation by UGT1A1, Relative to B-Estradiol
    1521-009X/46/12/1836–1846$35.00 https://doi.org/10.1124/dmd.118.083709 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 46:1836–1846, December 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics 6-Chloro-5-[4-(1-Hydroxycyclobutyl)Phenyl]-1H-Indole-3-Carboxylic Acid is a Highly Selective Substrate for Glucuronidation by UGT1A1, Relative to b-Estradiol Kimberly Lapham, Jian Lin, Jonathan Novak, Christine Orozco, Mark Niosi, Li Di, Theunis C. Goosen, Sangwoo Ryu, Keith Riccardi, Heather Eng, Kimberly O. Cameron, and Amit S. Kalgutkar Medicine Design, Pfizer Inc., Groton, Connecticut (K.L., J.L., J.N., C.O., M.N., L.D., T.C.G., S.R., K.R., H.E.); and Medicine Design, Pfizer Inc., Cambridge, Massachusetts (K.O.C., A.S.K.) Received July 24, 2018; accepted September 5, 2018 Downloaded from ABSTRACT 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic of PF-06409577 to M1 by UGT1A1 occurred in a relatively selective acid (PF-06409577) is a direct activator of the human b1-containing fashion, compared with b-estradiol (ES), a conventional probe adenosine monophosphate-activated protein kinase (ΑMPK) isoforms. substrate of UGT1A1. The Michaelis-Menten constant (KM)and The clearance mechanism of PF-06409577 in animals and humans Vmax values describing the formation of M1 from PF-06409577 in involves uridine diphosphoglucuronosyl transferase (UGT)–mediated hrUGT1A1 and microsomal preparations from human intestine, dmd.aspetjournals.org glucuronidation to an acyl glucuronide metabolite of PF-06409577 liver, and kidney ranged from 131 to 212 mM(KM) and 107–3834 [(2S,3S,4S,5R,6S)-6-((6-chloro-5-(4-(1-hydroxycyclobutyl)phenyl)- pmol/min per milligram (Vmax) in the presence of 2% bovine serum 1H-indole-3-carbonyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2- albumin.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Varicose Veins
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Varicose Veins Chemical Activity Count (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 1 (+)-CATECHIN 7 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 2 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 1 (+)-PRAERUPTORUM-A 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ACETOXYCOLLININ 1 (-)-ALPHA-BISABOLOL 2 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-DICENTRINE 1 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 3 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 1 (-)-EPIGALLOCATECHIN-3-O-GALLATE 2 (-)-EPIGALLOCATECHIN-GALLATE 3 (-)-HYDROXYJASMONIC-ACID 1 Chemical Activity Count (-)-N-(1'-DEOXY-1'-D-FRUCTOPYRANOSYL)-S-ALLYL-L-CYSTEINE-SULFOXIDE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 2 (15:1)-CARDANOL 1 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 2 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 1,7-BIS(4-HYDROXY-3-METHOXYPHENYL)-1,6-HEPTADIEN-3,5-DIONE 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 3 1-(METHYLSULFINYL)-PROPYL-METHYL-DISULFIDE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 2 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11-HYDROXY-DELTA-8-THC 1 11-HYDROXY-DELTA-9-THC 1 12,118-BINARINGIN 1 12-ACETYLDEHYDROLUCICULINE
    [Show full text]